Tag: Dr. Marty Makary

The Power of Natural Immunity

Guest Post by Dr. Marty Makary

The news about the U.S. Covid pandemic is even better than you’ve heard. Some 80% to 85% of American adults are immune to the virus: More than 64% have received at least one vaccine dose and, of those who haven’t, roughly half have natural immunity from prior infection. There’s ample scientific evidence that natural immunity is effective and durable, and public-health leaders should pay it heed.

Only around 10% of Americans have had confirmed positive Covid tests, but four to six times as many have likely had the infection. A February study in Nature used antibody screenings in late summer 2020 to estimate there had been seven times as many actual cases as confirmed cases. A similar study, by the University of Albany and New York State Department of Health, revealed that by the end of March 2020—the first month of New York’s pandemic—23% of the city’s population had antibodies. That share necessarily increased as the pandemic spread.

Continue reading “The Power of Natural Immunity”

A Mainstream Academic Research Superstar Starts to Question Things

Via Trial Site News

A Mainstream Academic Research Superstar Starts to Question Things

Recently, Dr. Marty Makary, a professor at the Johns Hopkins School of Medicine, Bloomberg School of Public Health and Carey Business School, and also Editor-in-Chief at MEDPAGETODAY®, wrote an editorial in the Wall Street Journal (WSJ) calling out the society-wide push by the nation’s government agencies, academic medical centers, industry, and great majority of mass media to vaccinate all children as a concerted effort to save lives. It turns out, writes Makary, that based on data from the U.S. Centers for Disease Control and Prevention (CDC), the total number of children under 18 that have died with a COVID-19 diagnostic code associated with their record comes out to 335.

Makary shares that despite the fact that the CDC employs 21,000 people, no one there has systematically investigated the cause of each child’s death, in an effort to determine if COVID was actually involved or if the death was the result of a preexisting condition. But, the Johns Hopkins professor asks, how could the CDC Advisory Committee on Immunization Practices conclude back in May that “the benefits of two-dose vaccination outweigh the risks for all kids 12 to 15”? Unless they have come to a prerequisite solution that’s overwhelmingly detached from reality, what data drove their conclusion?

Continue reading “A Mainstream Academic Research Superstar Starts to Question Things”